Spiderview & Synescope (v3.10)

The multipurpose digital ECG Holter recorder.
Spider View device

Spiderview – a multipurpose digital Holter recorder.

Spiderview is a Holter recorder that is small, compact, easy to use and, above all, conceived for multipurpose applications.

The wide LCD display and the flower-like keypad help to make programming easy.

Spiderview’s initialization tests improve the accuracy and reliability of recordings. Use Spiderview with your Multichannel-Multiday Synescope software.

 
 

Spiderview Plus

SpiderView Plus is a premium Holter recorder designed for research centers requiring superior signal quality for quantitative ECG analysis and other research applications.

In addition to all the functions available with the standard SpiderView Holter recorder, SpiderView Plus features long-term high-resolution recordings (1000 Hz) instead of the usual 20 minutes.

Synescope

A paramount Holter software in ambulatory ECG.

Synescope is a high-end ECG Holter analysis software. It is a Multichannel and Multiday analyzer that exploits the multipurpose applications of SpiderSAS and Spiderview recorders.

Synescope is compatible with all MicroPort CRM recorders.

 

Synescope (v3.10)

Synescope (V3.10) embeds cardiac arrhythmias engine to analyze Multiday, Multichannel recordings.

Up to 4 days, up to 12 channels

High Resolution recording with shielded cable

Rhythm, ST, pacemaker, histograms, events

Standard Heart Rate Variability

Edition toolbox, customizable reports

Connectivity module (network, email, webmail)

Compatible with Synecom

Additional options:

  • Import/Export data 
  • Multiple languages are available: Dutch, English, French, German, Hungarian, Italian, Japanese, Portuguese, Russian, Spanish, and Swedish.

Synescope (v3.10) software may not be available for sale in your country or your area. For further information on product availability, please contact your local representative.

References

  1. Thomakos P, et al. Cigarette Smoking Is Associated with Prolongation of the QTc Interval Duration in Patients with Type 2 Diabetes Mellitus. Int J Endocrinol. 2013;2013:329189.
  2. Extramiana F, et al. Beat-to-beat T-wave amplitude variability in the long QT syndrome. Europace. 2010;12:1302–07.
  3. Sobue Y, et al. Beat-to-beat variability of T-wave amplitude for the risk assessment of ventricular tachyarrhythmia in patients without structural heart disease. Europace. 2011;13:1612–18.
  4. Stojkovic S, et al.T-Wave Variability for the Prediction of Fast Ventricular Arrhythmias, Prospective, Observer-Blind Study.
    Circulation. 2015;79:318–24.
Exemplary message

By continuing to browse this website you confirm that you are a healthcare professional.